Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

:DNA

6.80

+0.40 (+6.25%)

7:59:12 PM EDT: $6.80 0.00 (0.00%)

Market Cap (Intraday)	421.64M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$42.93 Million
Adjusted EPS	-$1.21

See more estimates

10-Day MA	$6.93
50-Day MA	$8.73
200-Day MA	$10.39

See more pivots

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A Stock, :DNA

27 Drydock Avenue, 8th floor, Boston, Massachusetts 02210

United States of America

Phone: +1.877.422.5362

Number of Employees: 834

http://www.ginkgobioworks.com

Description

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.